investordatabase.org

Privilège Ventures

privilege-ventures.com Direct investor

Privilège Ventures is a Swiss early-stage investor focused on HealthTech, MedTech, and Longevity. It provides capital and operational support to founders, with a portfolio of over 20 companies.

Privilège Ventures is a venture capital firm headquartered in Lugano, Switzerland, founded in 2021. It invests directly in companies, from seed to Series A, in HealthTech, MedTech and longevity. 23 portfolio companies, as it reports.

“We back founders early offering support on strategy, governance, operations and opening the right doors when it counts.”

Privilège Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries A
Headquarters
Lugano, Switzerland
Invests in
Switzerland, Europe
Sectors
HealthTech, MedTech, Longevity
Founded
2021
Portfolio
23 companies

Team, as Privilège Ventures publishes it

  • Jacqueline Ruedin Rüsch Founding Partner & CEO
  • Angelica Morrone Partner & CIO
  • Nicole Schimenti Business Operations Manager
  • Cesare Pezzini Venture Partner
  • Lucian Wagner Senior Advisor
  • Mershad Javan Venture Partner
  • Haena Kim Venture Partner
  • Didier Denat Chairman of the Board
  • Marco Nannini Board Member
  • Elisabeth Aloy Advisor
  • Sarah Clatterbuck Advisor

Names and roles exactly as listed on privilege-ventures.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 22 co-investors found.

and 12 more — the graph.

Where this comes from

Every fact above was read from a page Privilège Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 6087 · added 2026-09-03 · link last verified 2026-09-05 · confidence high

Similar investors

Listed under